Sofie Mohlin

32 papers receiving 1.0k citations

Peers

Sofie Mohlin
Comparison fields: 5 of 93
  • Cancer Research 351
  • Neurology 208
  • Oncology 206
  • Molecular Biology 431
  • Immunology 127
Replace Eva López with:
Eva López Spain
Laura di Blasio Italy
Mélanie Héroult Germany
Hatem E. Sabaawy United States
Shane P. Herbert United Kingdom
Sumithra Urs United States
Urs H. Langen United States
Zhenwei Zhao China
Lea Scheppke United States
Tom T. Chen United States
Sofie Mohlin relative to Eva López Spain Eva López's profile →
Citations per field
00.5×4.7×
Eva López · 1×
Citations per year

Countries citing papers authored by Sofie Mohlin

Since Specialization
Citations

This map shows the geographic impact of Sofie Mohlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofie Mohlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofie Mohlin more than expected).

Fields of papers citing papers by Sofie Mohlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofie Mohlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofie Mohlin. The network helps show where Sofie Mohlin may publish in the future.

Co-authors

The 25 scholars most cited alongside Sofie Mohlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sofie Mohlin Line = papers co-authored together Sofie Mohlin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2020184
2 2016145
3 202085
4 201576
5 201763
6 201462
7 201744
8 201340
9 201832
10 201430
11 201929
12 201528
13 201127
14 201826
15 202024
16 202020
17 201720
18 201316
19 201414
20 201914

About Sofie Mohlin

Sofie Mohlin is a scholar working on Cancer Research, Neurology, Oncology, Surgery and Molecular Biology, having authored 33 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (14 papers), Neuroblastoma Research and Treatments (14 papers), Adrenal and Paraganglionic Tumors (5 papers), Epigenetics and DNA Methylation (4 papers), Cancer Cells and Metastasis (3 papers), Lung Cancer Research Studies (3 papers), Pluripotent Stem Cells Research (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). The work is most often cited by research in Cancer Research (351 citations), Neurology (208 citations), Oncology (206 citations), Molecular Biology (431 citations) and Immunology (127 citations). Sofie Mohlin has collaborated with scholars based in Sweden, United States and Finland. Frequent co-authors include Sven Påhlman, Caroline Wigerup, Daniel Bexell, Emma U. Hammarlund, Kristoffer von Stedingk, Emily Flashman, Francesco Licausi, Martin Johansson, Esther Bridges and Hani N. Alsafadi. Their work appears in journals such as Experimental Cell Research, eLife, Oncogene, Biochemical and Biophysical Research Communications and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026